Justin Sullivan/Getty Photographs Information
Walgreens (Nasdaq: WBAThe U.S. Division of Justice ((DoJ)) introduced that CityMD, an pressing care supplier backed by ), has agreed to pay greater than $12 million to resolve allegations that the corporate falsely represented authorities funds associated to COVID-19 testing through the pandemic. .
The settlement is as follows One grievance alleges that New York-based CityMD submitted false claims and even sought funds for insured people as a part of a federal program focusing on COVID-19 testing for the uninsured.
The U.S. Division of Justice mentioned CityMD, which operates roughly 177 pressing care services in New York and New Jersey, filed these claims in opposition to this system or commissioned exterior experiments between February 4, 2020, and April 5, 2022. Chambers filed such claims in opposition to this system.
“We can not and won’t tolerate the alleged misuse of those funds. At present’s settlement ensures that funds improperly obtained shall be returned to the federal government,” mentioned U.S. Legal professional Philip Sellinger.
CityMD joined Walgreens’ (WBA) portfolio in early 2023 after the previous’s father or mother firm Summit Well being agreed to be acquired by WBA-backed VillageMD for about $8.9B, with funding from Cigna (NYSE:CI) Pharmacy Advantages Supervisor, Evernorth,
